The aim of the study was to investigate the feasibility of Epidermal Growth Factor Receptor (EGFR) measurement in bladder washings of patients affected by non-muscle-invasive bladder cancer (NMIBC) and its prognostic role in identifying risk subgroups and predicting disease recurrence and progression.
Di Maida, F., Mari, A., Scalici Gesolfo, C., Cangemi, A., Allegro, R., Sforza, S., et al. (2019). Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression. CLINICAL GENITOURINARY CANCER [10.1016/j.clgc.2019.04.008].
Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression
Scalici Gesolfo, Cristina;Cangemi, Antonina;Allegro, Rosalinda;Russo, Antonio;Serretta, VincenzoSupervision
2019-01-01
Abstract
The aim of the study was to investigate the feasibility of Epidermal Growth Factor Receptor (EGFR) measurement in bladder washings of patients affected by non-muscle-invasive bladder cancer (NMIBC) and its prognostic role in identifying risk subgroups and predicting disease recurrence and progression.
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S155876731930134X-main.pdf
Solo gestori archvio
Dimensione
543.34 kB
Formato
Adobe PDF
|
543.34 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
